Results 11 to 20 of about 40,837 (237)

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension

Frontiers in Cardiovascular Medicine, 2021
Objectives: Evidence has shown that angiotensin-converting enzyme 2 (ACE2), which can be upregulated after angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, may play a dual role in the pathogenesis and ...
Jing Ma, Jing Ma, Jing Ma, Xiaowei Shi, Xiaowei Shi, Jiong Yu, Jiong Yu, Feifei Lv, Jian Wu, Jian Wu, Xinyu Sheng, Xinyu Sheng, Qiaoling Pan, Qiaoling Pan, Jinfeng Yang, Jinfeng Yang, Hongcui Cao, Hongcui Cao, Lanjuan Li, Lanjuan Li   +19 more
doaj   +1 more source

The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis

Frontiers in Pharmacology, 2021
Background: Acute kidney injury (AKI) may increase the risk of chronic kidney disease (CKD), development of end-stage renal disease (ESRD), and mortality.
Jui-Yi Chen, I-Jung Tsai, Heng-Chih Pan, Heng-Chih Pan, Hung-Wei Liao, Javier A. Neyra, Vin-Cent Wu, Vin-Cent Wu, Jeff S. Chueh, Jeff S. Chueh   +9 more
doaj   +1 more source

Preparation, Characterization, and Cytoprotective Effects on HUVECs of Fourteen Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides From Protein Hydrolysate of Tuna Processing By-Products

Frontiers in Nutrition, 2022
To effectively utilize skipjack tuna (Katsuwonus pelamis) processing by-products to prepare peptides with high angiotensin-I-converting enzyme (ACE) inhibitory (ACEi) activity, Neutrase was selected from five kinds of protease for hydrolyzing skipjack ...
Qian-Qian Qiao, Qian-Bin Luo, Shi-Kun Suo, Yu-Qin Zhao, Chang-Feng Chi, Bin Wang   +5 more
doaj   +1 more source

Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension

Clinical and Experimental Hypertension, 2017
We report a 14-year-old boy with recurrent episodes of headache caused by uncontrolled hypertension. The diagnosis of renovascular hypertension due to Takaysu arteritis (TA) was made based on an increase in erythrocyte sedimentation rate (ESR) and C ...
Xin Zhang, Ying Xu, Xiaoping Chen, Si Wang, Xinran Li, Xin Yan   +5 more
doaj   +1 more source

Path mechanism and spatial spillover effect of green technology innovation on agricultural CO2 emission intensity: A case study in Jiangsu Province, China

Ecological Indicators, 2023
Green technology innovation (GTI) is one of the most important factors influencing agricultural carbon emission intensity (ACEI). Various studies have explored the impact of GTI on ACEI, but the path mechanism has not been fully explained.
Jing Rong, Jun Hong, Quan Guo, Zhou Fang, Shikun Chen   +4 more
doaj   +1 more source

Hypertension and Headache: the Effect of Antihypertensive Drugs

Рациональная фармакотерапия в кардиологии, 2019
Headache is considered to be one of the main symptoms of arterial hypertension (HT). Complaints of headache are presented by many patients with HT: from 44% to 87%.
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova   +2 more
doaj   +1 more source

User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study

BMC Nephrology, 2021
Background Vascular calcification is a prominent feature in chronic kidney disease (CKD) and diabetes mellitus. A recent report suggests that angiotensin II is protective to vascular calcification.
Kaori Takaori, Hirotsugu Iwatani, Masafumi Yamato, Takahito Ito   +3 more
doaj   +1 more source

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease

Frontiers in Pharmacology, 2023
Introduction: As in other chronic conditions, medication adherence is important in the treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non-adherence to angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin ...
Martin Wawruch, Miriam Petrova, Tomas Tesar, Jan Murin, Patricia Schnorrerova, Martina Paduchova, Denisa Celovska, Beata Havelkova, Michal Trnka, Sofa D. Alfian, Sofa D. Alfian, Emma Aarnio   +11 more
doaj   +1 more source

Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations

Vascular Health and Risk Management, 2022
Giovanna Gallo,1 Massimo Volpe,1 Speranza Rubattu1,2 1Department of Clinical and Molecular Medicine, Sapienza University of Rome, Sant’Andrea Hospital, Rome, Italy; 2IRCCS Neuromed, Pozzilli, IS, ItalyCorrespondence: Speranza Rubattu, Department of ...
Gallo G, Volpe M, Rubattu S
doaj  

COVID-19 clinical outcomes in patients with and without ongoing therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Arterial Hypertension, 2022
BACKGROUND: The are conflicting reports on the effects of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) continued treatment on clinical outcomes in COVID-19 patients.
Ahmed Nafakhi, Ihsan Rabeea, Rasha AL-Darraji, Hussein Nafakhi, Ahmed Mechi, Alhan Al-khalidi   +5 more
doaj   +1 more source